Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/183838
Title: Drug-Biopolymer Dispersions: Morphology- and Temperature- Dependent (Anti)Plasticizer Effect of the Drug and Component-Specific Johari–Goldstein Relaxations
Author: Valenti, Sofia
Valle, Luis J. del
Romanini, Michela
Mitjana, Meritxell
Puiggalí, Jordi
Tamarit, Josep Lluís
Macovez, Roberto
Keywords: Farmacologia molecular
Espectroscòpia d'impedància
Molecular pharmacology
Impedance spectroscopy
Issue Date: 24-Feb-2022
Publisher: MDPI AG
Abstract: Amorphous molecule-macromolecule mixtures are ubiquitous in polymer technology and are one of the most studied routes for the development of amorphous drug formulations. For these applications it is crucial to understand how the preparation method affects the properties of the mixtures. Here, we employ differential scanning calorimetry and broadband dielectric spectroscopy to investigate dispersions of a small-molecule drug (the Nordazepam anxiolytic) in biodegradable polylactide, both in the form of solvent-cast films and electrospun microfibres. We show that the dispersion of the same small-molecule compound can have opposite (plasticizing or antiplasticizing) effects on the segmental mobility of a biopolymer depending on preparation method, temperature, and polymer enantiomerism. We compare two different chiral forms of the polymer, namely, the enantiomeric pure, semicrystalline L-polymer (PLLA), and a random, fully amorphous copolymer containing both L and D monomers (PDLLA), both of which have lower glass transition temperature (Tg) than the drug. While the drug has a weak antiplasticizing effect on the films, consistent with its higher Tg, we find that it actually acts as a plasticizer for the PLLA microfibres, reducing their Tg by as much as 14 K at 30%-weight drug loading, namely, to a value that is lower than the Tg of fully amorphous films. The structural relaxation time of the samples similarly depends on chemical composition and morphology. Most mixtures displayed a single structural relaxation, as expected for homogeneous samples. In the PLLA microfibres, the presence of crystalline domains increases the structural relaxation time of the amorphous fraction, while the presence of the drug lowers the structural relaxation time of the (partially stretched) chains in the microfibres, increasing chain mobility well above that of the fully amorphous polymer matrix. Even fully amorphous homogeneous mixtures exhibit two distinct Johari–Goldstein relaxation processes, one for each chemical component. Our findings have important implications for the interpretation of the Johari–Goldstein process as well as for the physical stability and mechanical properties of microfibres with small-molecule additives.
Note: Reproducció del document publicat a: https://doi.org/10.3390/ijms23052456
It is part of: International Journal of Molecular Sciences 2022, vol 23, num 5
URI: https://hdl.handle.net/2445/183838
Related resource: https://doi.org/10.3390/ijms23052456
ISSN: 1422-0067
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))

Files in This Item:
File Description SizeFormat 
2022_IntJMolSci_Puiggali_DrugBiopolymer.pdf5.96 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons